| Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial JS Weber, SP D'Angelo, D Minor, FS Hodi, R Gutzmer, B Neyns, ... The lancet oncology 16 (4), 375-384, 2015 | 2960 | 2015 |
| Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer U Sahin, E Derhovanessian, M Miller, BP Kloke, P Simon, M Löwer, ... Nature 547 (7662), 222-226, 2017 | 2199 | 2017 |
| Chemosensitisation of malignant melanoma by BCL2 antisense therapy B Jansen, V Wacheck, E Heere-Ress, H Schlagbauer-Wadl, C Hoeller, ... The Lancet 356 (9243), 1728-1733, 2000 | 646 | 2000 |
| Overall survival in patients with advanced melanoma who received nivolumab versus investigator’s choice chemotherapy in CheckMate 037: a randomized, controlled, open-label … J Larkin, D Minor, S D'Angelo, B Neyns, M Smylie, WH Miller Jr, ... Journal of clinical oncology 36 (4), 383, 2018 | 514 | 2018 |
| Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial PA Ascierto, M Del Vecchio, C Robert, A Mackiewicz, V Chiarion-Sileni, ... The Lancet Oncology 18 (5), 611-622, 2017 | 501 | 2017 |
| Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines K Peris, MC Fargnoli, C Garbe, R Kaufmann, L Bastholt, NB Seguin, ... European Journal of cancer 118, 10-34, 2019 | 486 | 2019 |
| A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis K Kollmann, G Heller, C Schneckenleithner, W Warsch, R Scheicher, ... Cancer cell 24 (2), 167-181, 2013 | 360 | 2013 |
| European consensus-based interdisciplinary guideline for melanoma. Part 2: treatment–update 2019 C Garbe, T Amaral, K Peris, A Hauschild, P Arenberger, L Bastholt, ... European Journal of Cancer 126, 159-177, 2020 | 321 | 2020 |
| Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised … AMM Eggermont, CU Blank, M Mandalà, GV Long, VG Atkinson, S Dalle, ... The lancet oncology 22 (5), 643-654, 2021 | 290 | 2021 |
| Migratory dermal dendritic cells act as rapid sensors of protozoan parasites LG Ng, A Hsu, MA Mandell, B Roediger, C Hoeller, P Mrass, ... PLoS pathogens 4 (11), e1000222, 2008 | 287 | 2008 |
| European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment AJ Stratigos, C Garbe, C Dessinioti, C Lebbe, V Bataille, L Bastholt, ... European Journal of Cancer 128, 83-102, 2020 | 230 | 2020 |
| Stimulation of the mitogen-activated protein kinase via the A2A-adenosine receptor in primary human endothelial cells V Sexl, G Mancusi, C Höller, E Gloria-Maercker, W Schütz, M Freissmuth Journal of Biological Chemistry 272 (9), 5792-5799, 1997 | 225 | 1997 |
| European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organization for Research and Treatment of Cancer (EORTC). Diagnosis and … K Peris, MC Fargnoli, C Garbe, R Kaufmann, L Bastholt, NB Seguin, ... Eur J Cancer 118, 10-34, 2019 | 214 | 2019 |
| European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention AJ Stratigos, C Garbe, C Dessinioti, C Lebbe, V Bataille, L Bastholt, ... European journal of cancer 128, 60-82, 2020 | 194 | 2020 |
| MR imaging of the her2/neu and 9.2. 27 tumor antigens using immunospecific contrast agents MA Funovics, B Kapeller, C Hoeller, HS Su, R Kunstfeld, S Puig, ... Magnetic resonance imaging 22 (6), 843-850, 2004 | 177 | 2004 |
| ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee Annals of Oncology 31 (11), 1435-1448, 2020 | 170 | 2020 |
| Efficacy of BMS-986016, a monoclonal antibody that targets lymphocyte activation gene-3 (LAG-3), in combination with nivolumab in pts with melanoma who progressed during prior … PA Ascierto, P Bono, S Bhatia, I Melero, MS Nyakas, IM Svane, J Larkin, ... Annals of Oncology 28, v611-v612, 2017 | 167 | 2017 |
| Activation of Mitogen-activated Protein Kinase by the A2A-adenosine Receptor via a rap1-dependent and via a p21ras-dependent Pathway MG Seidel, M Klinger, M Freissmuth, C Höller Journal of Biological Chemistry 274 (36), 25833-25841, 1999 | 166 | 1999 |
| Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy F Moik, WSE Chan, S Wiedemann, C Hoeller, F Tuchmann, MB Aretin, ... Blood, The Journal of the American Society of Hematology 137 (12), 1669-1678, 2021 | 156 | 2021 |
| Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC) C Lebbe, C Garbe, AJ Stratigos, C Harwood, K Peris, V Del Marmol, ... European Journal of Cancer 114, 117-127, 2019 | 144 | 2019 |
Dirk SchadendorfProfessor für Dermatologie, University Hospital Essen; University of Duisburg-EssenVerified email at uk-essen.de
